Smith & Nephew plc is a global medical technology enterprise dedicated to the development, manufacturing, and worldwide commercialization of an extensive array of medical devices. Its product portfolio spans several key areas. In orthopedics, the company provides knee implants for replacement procedures, hip implants for joint reconstruction, and trauma and extremities products, including both internal and external fixation devices, crucial for stabilizing severe fractures and correcting deformities. For sports medicine, Smith & Nephew offers joint repair solutions tailored for surgeons. This includes specialized instruments, advanced technologies, and implants essential for minimally invasive joint surgeries, targeting soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. Additionally, the firm supplies arthroscopic enabling technologies that enhance surgical visualization and intervention within joints. This suite encompasses fluid management equipment for surgical access, high-definition cameras, digital imaging capture systems, scopes, light sources, and monitors. It also features radiofrequency, electromechanical, and mechanical tissue resection devices, alongside hand instruments for precise tissue removal. The company also provides dedicated ear, nose, and throat (ENT) solutions. Its Advanced Wound Management division delivers comprehensive solutions for the treatment and prevention of acute and chronic wounds, covering conditions like leg, diabetic, and pressure ulcers, burns, and post-operative wounds. This segment includes advanced wound bioactives, comprising biologics and other bioactive technologies for debridement, dermal repair, and regeneration. Regenerative medicine products, such as skin, bone graft, and articular cartilage substitutes, are also offered. Furthermore, Smith & Nephew provides advanced wound devices, including traditional and single-use negative pressure wound therapy systems, and hydrosurgery technology. Primarily serving healthcare providers globally, Smith & Nephew plc was founded in 1856 and is headquartered in Watford, United Kingdom.
The current price of SNNUF is $13.95 USD — it has increased by +6.49% in the past 24 hours. Watch Smith & Nephew stock price performance more closely on the chart.
What is Smith & Nephew stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Smith & Nephew stocks are traded under the ticker SNNUF.
Is Smith & Nephew stock price growing?▼
SNNUF stock has risen by +6.49% compared to the previous week, the month change is a -6.44% fall, over the last year Smith & Nephew has showed a -4.45% decrease.
What is Smith & Nephew market cap?▼
Today Smith & Nephew has the market capitalization of 5.89B
When is the next Smith & Nephew earnings date?▼
Smith & Nephew is going to release the next earnings report on August 04, 2026.
What were Smith & Nephew earnings last quarter?▼
SNNUF earnings for the last quarter are 0.59 USD per share, whereas the estimation was 0.58 USD resulting in a +2.16% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Smith & Nephew revenue for the last year?▼
Smith & Nephew revenue for the last year amounts to 6.16B USD.
What is Smith & Nephew net income for the last year?▼
SNNUF net income for the last year is 625M USD.
Does Smith & Nephew pay dividends?▼
Yes, SNNUF dividends are paid semi-annual. The last dividend per share was 0.24 USD. As of today, Dividend Yield (FWD)% is 2.7%.
How many employees does Smith & Nephew have?▼
As of July 07, 2026, the company has 17,349 employees.
In which sector is Smith & Nephew located?▼
Smith & Nephew operates in the Health & Wellness sector.
When did Smith & Nephew complete a stock split?▼
The last stock split for Smith & Nephew was on October 15, 2014 with a ratio of 2.5:1.
Where is Smith & Nephew headquartered?▼
Smith & Nephew is headquartered in Watford, United Kingdom.